A.M suministros CONTR 2025 0000519166
Deadline:N/A
Contract award
Estimated value
€4,010,802,463.28
Contract type
Framework agreement
Duration
24 months
Bidders
Awarded bidders
Name
Abbvie Spain, S.L.
Alexion Pharma Spain, S.L.
Almirall, S.A.
Alnylam Pharmaceuticals Spain, S.L.
Amgen, S.A.
Amicus Therapeutics, S.L.U.
Astrazeneca Farmacéutica Spain, S.L.
Bayer Hispania, S.L.
Beone Medicines Esp, S.L.U.
Biogen Spain, S.L.
Biomarin Pharmaceuticals España, S.L.
Bristol-Myers Squibb, S.A.
CSL Behring, S.A.
Daiichi Sankyo España, S.A.
Gilead Sciences, S.L.
Glaxosmithkline, S.A.
Incyte Biosciences Iberia, S.L.
Ipsen Pharma, S.A.U.
Janssen-Cilag, S.A.
Jazz Pharmaceuticals Iberia, S.L.
Kyowa Kirin Farmacéutica, S.L.
Laboratorios Servier, S.L.
Laboratorios Viiv Healthcare, S.L.
Lilly, S.A.
Merck, S.L.
Novartis Farmacéutica, S.A.
Novo Nordisk Pharma, S.A.
Organon Salud, S.L.
Pfizer, S.L.
Pierre Fabre Ibérica, S.A.
Regeneron Spain, S.L.U.
Roche Farma, S.A.
Sanofi Aventis, S.A.
Swedish Orphan Biovitrum, S.L.
Takeda Farmacéutica España, S.A.
Teva Pharma, S.L.
UCB Pharma, S.A.
Vertex Pharmaceuticals Spain, S.L
